- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01705054
Angina Prevalence and Provider Evaluation of Angina Relief (APPEAR)
October 14, 2021 updated by: Saint Luke's Health System
The purpose of this study is describe the frequency of chest pain and how chest pain impacts patients' quality of life in the outpatients with chronic coronary artery disease in contemporary cardiology practice settings.
Study Overview
Status
Completed
Conditions
Detailed Description
The primary goals in the management of stable coronary artery disease (CAD) are to reduce risk factors for heart attack and to control the symptoms of angina (chest pain).
Ideally angina is well controlled with medications alone, but invasive procedures are a valuable option for patients with persistent angina.
The amount of angina among patients with stable CAD in the outpatient setting, however, is unknown.
An Australian study reported that almost 1 in 3 patients with stable angina being treated by primary care doctors had angina at least once a week, which was associated with worse quality of life.
We propose to examine the burden of angina in outpatients with stable CAD who are being medically managed by cardiologists in the United States through administration of a one-time survey.
The information from this study could ultimately help improve management of stable CAD and angina and illuminate potential underuse of revascularization.
While cardiologists are generally expected to provide better angina control than primary care doctors, establishing the prevalence of angina among the best providers will help with a framework for interpreting symptom control among other practitioners.
Study Type
Observational
Enrollment (Actual)
1246
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Missouri
-
Kansas City, Missouri, United States, 64111
- Saint Luke's Hospital of Kansas City
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Outpatient cardilogy practice.
Description
Inclusion Criteria:
- Coronary artery disease patients being seen in a participating cardiology office for a scheduled clinic visit who agree to take the survey.
Exclusion Criteria:
- Too ill to take survey
- Previously completed this survey
- Refused to participate
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
|---|
|
Outpatient Coronary Artery Disease Patient
CAD patients being seen in a participating cardiology office for a scheduled clinic visit who agree to take the survey.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Seattle Angina Questionnaire
Time Frame: One time cardiology office visit.
|
Percentage of patients with frequent angina (>1 episode/week) as measured by the Seattle Angina Questionnaire (SAQ).
|
One time cardiology office visit.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Quality of Life
Time Frame: One time cardiology office visit.
|
Evaluate the impact of frequent angina on Quality of Life (as measured by the SAQ)
|
One time cardiology office visit.
|
|
Physician Perspective
Time Frame: One time cardiology office visit.
|
Identifying differences between patients' and cardiologists' assessment of angina control
|
One time cardiology office visit.
|
|
Cardiology practices angina control.
Time Frame: One time cardiology office visit.
|
Evaluate the differences in angina control between cardiology practices.
|
One time cardiology office visit.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Faraz Kureshi, MD, Saint Luke's Hospital of Kansas City
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2013
Primary Completion (Actual)
July 1, 2015
Study Completion (Actual)
July 22, 2015
Study Registration Dates
First Submitted
September 25, 2012
First Submitted That Met QC Criteria
October 10, 2012
First Posted (Estimate)
October 12, 2012
Study Record Updates
Last Update Posted (Actual)
October 19, 2021
Last Update Submitted That Met QC Criteria
October 14, 2021
Last Verified
October 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IN-US-259-0157
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stable Coronary Artery Disease CAD
-
Beijing Anzhen HospitalRecruitingStable Coronary Artery Disease CADChina
-
Dolnośląskie Centrum Chorób Serca im.prof. Zbigniewa...Medical Research Agency, PolandRecruitingChronic Coronary Syndrome | Stable Coronary Artery Disease CADPoland
-
UMC UtrechtNot yet recruitingStable Angina Pectoris | Coronary Artery Disease (CAD) | Coronary Microvascular Dysfunction (CMD) | Vasospasm, Coronary | Obstructive Coronary Artery Disease
-
Academisch Medisch Centrum - Universiteit van Amsterdam...RecruitingDrug Coated Balloon | Paclitaxel | Stable Coronary Artery Disease (CAD), Myocardial Infarction | Percutaneous Coronary Intervention (PCI) | CAD - Coronary Artery Disease | ACS (Acute Coronary Syndrome)Netherlands
-
Ribocure Pharmaceuticals ABCompletedStable Coronary Artery Disease CADSweden
-
Imperial College LondonRoyal Free Hospital NHS Foundation Trust; Mid and South Essex NHS Foundation... and other collaboratorsRecruitingCoronary Artery Disease(CAD) | Ischaemic Heart Desease | Angina (Stable)United Kingdom
-
Universidad Complutense de MadridNot yet recruitingStable Coronary Artery Disease (CAD), Myocardial Infarction
-
BayerNot yet recruitingStable Coronary Artery DiseaseBulgaria, Germany
-
AstraZenecaTerminatedStable Coronary Artery Disease (CAD), Myocardial InfarctionUnited States, France, Italy, Spain, Turkey, United Kingdom, Germany, China, Romania, Finland, Netherlands, Norway, Canada, Mexico, Argentina, Australia, Belgium, Denmark, Portugal, Korea, Republic of, India, Japan, Brazil, Colombia, Ve...
-
Hoffmann-La RocheRecruitingHealthy Volunteers | Stable Coronary Artery DiseaseNetherlands